Development of label-free gold nanoparticle based rapid colorimetric assay for clinical/point-of-care screening of cervical cancer
Tejaswini Appidi, Sushma V. Mudigunda, Suseela Kodandapani, Aravind Kumar Rengan
Abstract
Pap smear or biopsy), showed 96.42% sensitivity. With the detection time less than a minute and with no/minimal sample processing requirements, the proposed technique shows great potential for point-of-care as well as clinical screening of cervical cancer.
Topics & Concepts
Colloidal goldCervical cancerGold standard (test)Point of careCervical cancer screeningNanoparticleMedicineChemistryCancerNanotechnologyMaterials sciencePathologyInternal medicineAdvanced biosensing and bioanalysis techniquesAdvanced Nanomaterials in CatalysisNanocluster Synthesis and Applications